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Despite some delay with the winter edition, we once again 
present to you a SA Heart Newsletter packed with infor-
mation to help keep you informed; to assist you in your 
work and to keep us, as providers of cardiac health care, 
united and enthusiastic. Fragmentation of our health care 
system is a major stumbling block in the way of providing 
efficient, cost effective and high standard of care. The 
excellence which is achieved in units abroad is only pos-
sible through dedicated and intensive volume experienced 
people. To be the best you need to spend time observing 
and doing 10 000 hours’ worth of procedures. While we 
try to be everything to everybody, we do not have the time 
to be the best in everything. I am a supporter of group 
practices where resources, time and expertise can be best 
applied and utilised. Why is there so much antagonism 
towards centres of excellence? Why not rather join such a 
center and thus become part of the excellence rather than 
fighting your own battles? What is wrong with hospitals 
employing health care professionals? This will help pro-
mote adherence to guidelines and the collection of accu-
rate data while also utilising resources more efficiently. 
Incentives can certainly be adopted in order to reward 
excellence. This idea does not differ so much from the 
situation in the USA, about the only other country which 
presently has a majority private health care system.
The SA Heart annual congress 2014, the congress for you, 
will take place from 16 - 19 October 2014 in Durban. The 
innovative and exciting programme will cater for a range of 
needs and tastes. ESC Global Scientific Activities, which will 
bring the ESC highlights to the SA Heart congress, will add 
even more value to the experience of attendees. For your 
benefit the programme has been structured to facilitate 
your attendance at our AGM. The AGM is notoriously 
poorly attended, despite the opportunity it presents to 
participate in the planning and running of your society. 
Calls for nominations to serve on the SA Heart Exco and 
its committees will also have reached you by this time and 
if you have the courage, if you can contribute and if you 
can do even better by raising the management to a new 
level, you should definitely participate: even lobby for sup-
port and ask to be nominated. However, if you only wish to 
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criticise and you cannot improve or you choose to not 
participate and contribute, at least support those who do.
The SA Heart-SASCI STEMI Early reperfusion project is 
now available to all regions but without champions and 
regional leaders, we might need to resort to patient 
awareness and pressure to provide this most important 
project with momentum. It is not just about the few with 
STEMI being able to get primary PCI, but also about the 
hundreds with chest pain that will be assisted by an efficient 
network, which is operated by educated participants, 
towards appropriate care. This will all be done in a 
concerted effort to assist in the making of a right diagnosis 
and to help realise the cost effective management of health 
care. The present status is costly, mainly as a result of 
inefficient diagnosis with delayed inappropriate or sub-
optimal management which leaves a significant and unac-
ceptable downstream morbidity as sad legacy. Raise your 
hand, participate in the development of an efficient team 
and let this plan come together! 
Please exercise your right to gain knowledge and participate 
and read this newsletter carefully, seeking out your role 
within our cardiac society. While many colleagues have the 
opportunity, and are privileged, to participate in and learn 
from wonderful meetings around the world; I see little 
sharing of new knowledge amongst members of our own 
community. This newsletter provides a comfortable way 
of sharing your experience and views. We welcome all 
meeting reports for publication. The mark of good leader-
ship is to know when others can do better than you and, 
after many years as editor of this newsletter, there certainly 
must be a colleague who is passionate about what we do 
and which will take this newsletter to new heights.
At the ESC Congress 2014 in Barcelona you will find the 
SA Heart Booth in the ESC Plaza C370. The South African 
Tourism Bureau has come on board and helped with the 
design as well as covering the expenses. I hope to see 
more governmental and institutional participation in the 
future as the money and effort spent here may well be 
more efficient than spending millions on seminars that 
have no outcome. Talking of outcomes – SHARE – Our 
Research portfolio is looking forward to your participation 
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in projects, outcome based, which will have an impact on 
our practice and patient care. The SA Heart annual con-
gress 2015, organised by the Bloemfontein Branch, will be 
a stand-alone congress to be held at Sun City from 25 - 28 
October whilst for 2016 we are looking at joining forces 
with the 26th World Congress of the World Society of 
Cardio-thoracic Surgeons in Cape Town. We have not 
abandoned the prospect of a World Cardiology Congress 
for 2018.
SA Heart welcomes the opportunity for a closer relation-
ship and combined strategies with the Heart and Stroke 
Foundation as well as Industry. You will find informative 
contributions in this newsletter from HSF and SAMED. The 
activities and contributions from our SIGs, in matters 
pertaining to education and logistic and financial support 
for all members, are noteworthy and help strengthen SA 
Heart. The enthusiasm from the (at times neglected) 
paediatric cardiology and research groups as well as our 
new ISCAP group should inspire you to be part of that 
which is happening around you. It will certainly prove 
worth your while to read their reports with attention.
We congratulate Stellenbosch and Tygerberg Hospital with 
their combined echo-screening initiative in the Cape Flats 
together with the British Society of Echocardiography. 
There must be a huge opportunity to launch similar projects 
with our colleagues in Europe and elsewhere but we need 
local initiative and leadership to make this happen. The 
number of attendees at ISCAP meetings should serve as 
an example to other professionals. I hope that I am not 
naïve in thinking that this is not merely indicative of an 
attitude of to get and to take but also signifies an attitude 
of to give. PASCAR is growing and the use of terminology 
such as Task Force, Education, Eliminating Disease and 
Society Management promises exciting outcomes. Active 
involvement of our local leadership structures will help to 
ensure further growth in this regard. We certainly can 
achieve much more together, working as a team. I took 
part in Cardio Alex Egypt in 2013 and this year SA Heart, 
with Profs Andrew Sarkin and Francis Smit, continued our 
involvement. Congratulations to Prof Commerford who 
took up the responsibility of Chief Editor of CVJA. 
Africa PCR 2015 in Johannesburg is but one item which 
you should note in advance on your 2015 calendar. If you 
want to know more about the continued activities of 
our private practice committee, ethics committee, full 
time salaried committee, educational committee or SHARE 
and other SA Heart activities, please contact us via our 
Operations Officer, Erika Dau, at erika@saheart.org.
Enjoy your reading
Adriaan Snyders (asnyders@mweb.co.za)
President, SA Heart Association
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POPULAR CONGRESSES FOR 2014 
 CONGRESS DATE CITY COUNTRY
ESC CONgrESS 30 August - 3 September 2014 Barcelona Spain  
http://www.escardio.org/congresses/esc-2014/Pages/welcome.aspx
TCT 13 - 17 September 2014 Washington DC USA  
http://www.tct-cmrglobalgroupservices.com/pages/Home.aspx
SA HEART 2014 16 - 19 October 2014 Durban South Africa 
http://www.saheart.org
LAA LEfT ATrIAL AppENDAgE 14 - 15 November 2014 Frankfurt Germany 
http://www.cso-laa.org
AHA SCIENTIfIC SESSIONS 15 - 19 November 2014 Chicago USA  
http://www. scientificsessions.org
EUrO ECHO ImAgINg 3 - 6 December 2014 Vienna Austria  
http://www.escardio.org/congresses/euroecho-imaging-2014/Pages/welcome.aspx?hit=nav 
2ND WOrLD CONgrESS Of  5 - 7 December 2014 Vienna Austria 
CLINICAL LIpIDOLOgy 
http://www.clinical-lipidology.com
CArDIOrHyTHm 2015 30 January - 1 February 2015 Hong Kong Hong Kong 
http://www.cr2015.org
JIm 2015 12 - 14 February 2015 Rome  Italy  
http://www.jim-vascular.com
ACC.15 14 - 16 March 2015 San Diego USA  
http://www.scientifica sessions.org
AfrICApCr 2015 26 - 28 March 2015 Johannesburg South Africa 
http://www.africapcr.com
EUrOprEvENT 14 - 16 May 2015 Lisbon Portugal 
http://www.escardio.org
EUrOpCr 2015 19 - 22 May 2015 Paris France  
http://www.europcr.com
HEArTfAILUrE 2015 23 - 26 May 2015 Seville Spain  
http://www.escardip.org
AmErICAN SOCIETy ECHOCArDIOgrApHy (ASE) 13 - 16 June 2015 Boston USA
http://www.asescientificsessions.org  Massachusetts  
ESC 2015 29 August - 2 September 2015 London UK  
http://www.escardio.org
WSA 2015 (WOrLD CONgrESS ON CArDIOLOgy,   17 - 20 September 2015 Beijing China
ArrHyTHmIA, pACINg AND Ep)  
www.wsa2015.org
TCT2015 12 - 16 October 2015 San Francisco USA  
http://www.crf.org/tct  California
vENICE ArrHyTHmIA 16 - 18 October 2015 Venice Italy  
http://www.venicearrhythmia.org




T he theme for this year’s SA Heart Congress, “Bridging the Divide”, may be interpreted in many ways. Our field of interest serves the entire 
spectrum of society, ranging from privileged to under-
privileged patients, who are treated in turn in either the 
public or private sector by cardiologists, nursing pro-
fessionals, technologists and radiographers, all of whom 
receive training in different aspects of the patient’s 
management. 
Having a theme has spurred us on to think how we can 
bridge that divide which is proving to be quite a challenge!
ISCAP workshops 
As you are aware, the ISCAP workshops form a large part 
of the ISCAP initiative. Once again, delegates have 
responded in huge numbers to the meetings which have 
been held countrywide. Thank you for your interest, 
support and loyalty. A wide variety of topics are offered in 
order to address the diverse interests and needs of the 
Allied Professionals in their scope of practice.
Basic Life Support course 
A wonderful coup for ISCAP, in conjunction with Medtronic 
Africa, is the Basic Life Support course which will go from 
city to city, giving all clinical technologists and radiographers 
the opportunity to add this important item to their CVs, 
not to mention the CPD points!
ISCAP Crossroads course 
The ISCAP Crossroads Course, which has been a popular 
event for many years now, has also had large turnouts in 
the different cities.
2015 calendar 
The meeting schedule for the 2015 calendar year will be 
slightly altered. There will be fewer meetings, but they will 
be packed with more punch. The meetings will be 
predetermined, and most will be offered at a national level. 
ISCAP will be doing this in order to provide a higher 
standard of training, and to ensure quality education across 
South Africa.
As always, ISCAP would like to cover those topics which 
delegates are interested in, e.g. new techniques, innovative 
products, niche tools, new pharmaceutical regimes and, of 
course, pathophysiology which contributes to coronary 
artery disease, arrhythmic anomalies and congenital heart 
disease.
With the new hybrid Labs, ISCAP would like to add to the 
above with topics of interest e.g. EVAR, aortic stenting 
techniques, carotid intervention etc.
So, please step up and let us know what you would like us 
to include in the 2015 programme.
EuroPCR 
For the second time, ISCAP was invited to present at 
EuroPCR. This year the topic was Challenges Facing the 
Cath Lab Allied Professionals in South Africa. From the 
questions asked, it was obvious that delegates were very 
interested in the first world level of care offered by all 
hospitals and care givers in Southern Africa. The bad news 
is that in almost all countries represented at EuroPCR 
2014, there is still no legislation regarding practice or 
standardisation of professional requirements for the 
Allied staff working in Cath Labs. However, the struggle 
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entire spectrum of society, ranging  
from privileged to  
underprivileged patients.
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for recognition of the Allied Professionals will continue! 
Any ISCAP member who would like to represent ISCAP 
at EuroPCR 2015 must contact the ISCAP office for 
more information.
Synergy workshops
Training for Industry is planned. SASCI and ISCAP Industry 
representatives will work closely with the ISCAP Executive 
to develop the material for these workshops. The aim will 
be to design a programme that will determine and state 
the expectations, the clinical experience and the mini- 
mum standard of behaviour for all parties in the Cath Lab.
Cath Lab 
ISCAP has donated 50 Cardiac Catheterisation Training 
Manuals to Cath Lab Units across Africa. ISCAP wishes 
to initiate educational partnerships with cath labs across 
Africa. This partnership will ultimately benefit the inter-
ventional cardiology patient in Africa and this is a first step 
towards achieving this goal. 
ISCAP is proud to congratulate the Cath Lab personnel 
who completed the first Netcare Cath Laboratory course:
 ■  Phillip Oosthuizen, 
 ■  Isabel Bender and 
 ■  Linda Van Heerden. 
Netcare are planning the next course for January 2015 
based at the Netcare Training Academy in Auckland Park. 
Netcare has a Cath Lab forum working on the standards. 
The Netcare Cath Lab Course is open to all hospital groups 
but for other hospital groups to take part, assessors with 
cath lab experience need to be trained so that the 
formative and summative assessments can be done on 
the students. For more information please contact Helen 
Hatting on helen.hatting@netcare.co.za.
SA Heart Congress 
We are planning 2 sessions at the SA Heart Congress 
which will focus on the principle of “Time is Muscle”. These 
sessions are sure to be very exciting and I am confident 
that they will be successful.
Africa PCR 2015 
The needs analysis for Africa PCR 2015 has been completed 
for the Allied Professionals session. We have started to 
check the various interesting topics which have been 
forwarded to us, so that we can start planning the pro-
gramme. More details regarding the congress will be made 
available soon.
ISCAP would like to thank all our corporate supporters for 
their loyal support: Africa X-Ray Industrial & Medical, 
Amayeza Abantu Bio Medical, Angio Quip Medical Sup-
plies, Aspen Pharmacare, AstraZeneca, B Braun Medical, 
Baroque Medical, Biotronik SA, Boston Scientific South 
Africa, Cardiac Output, Cordis, Johnson and Johnson 
Medical, DISA Vascular, Edwards Lifesciences, Logan 
Medical and Surgical PTY, Medtronic Africa, Paragmed, 
Pharma Dynamics, Surgical Innovations, The Scientific 
Group, Torque Medical and Volcano Therapeutics SA.
If you want to learn more about  
these events or if you want to  
participate in any of the programmes,  
please contact Sanette Zietsman (ISCAp Office)  






T he South African Society of Cardiovascular Inter-vention (SASCI) has been very active in the first half of 2014. 
Memorandum of Understanding 
SASCI has recently signed a Memorandum of Under-
standing with Discovery Health which will see them visiting 
your practice with a proposal for voluntarily participation in 
a global fee arrangement for suspected IHD patients.  
Coding 
Coding however remains a major challenge requiring 
extensive time. Even with inclusion in SAMA, DBM 
individual funders (administrators) still need to decide to 
firstly include new codes in their coding structure and then 
decide on the funding level. SASCI is working to make 
claiming a less cumbersome and complex procedure. JP 
Theron must be acknowledged for his hard work in putting 
together a coding handbook for cardiology. The first draft 
will be available for review by the end of June and will be 
sent to the Exco for comment. Lenny Steingo, Mark 
Abelson and David Jankelow have been very involved in 
the process. This information will eventually be 
communicated to members and funders and will hopefully 
lead to a reduced number of queries in future.
AfricaPCR 
In our previous newsletter we reported on the successful 
AfricaPCR Course 2014. We are currently in the planning 
stages of the second standalone AfricaPCR Course in 2015. 
A needs analysis has been prepared and it has been 
discussed with the AfricaPCR Board. 
SAvE THE DATE!
AfricaPCR 2015
The Forum, The Campus, Johannesburg, South Africa
26 - 28 march, 2015
visiting Professor Programme 
We also reported on the Visiting Professor Programme 
2014 - Prof Tony Gershlick (University of Leicester, UK) 
left a legacy that will remain for a long time in the respective 
departments and with the individuals who interacted with 
him during his 2 month visit. SASCI has a standing invita- 
tion for VPP 2015 with Prof David Holmes (USA) and we 
hope to finalise the details in the near future. Medtronic 
must be thanked for their longstanding and continued 
support of this programme and thanks also goes to Pharma 
Dynamics who continue to sponsor the Visiting Professor 
Evening Lecture series. 
Rotablator meeting 
Locally SASCI also hosted a very successful Rotablator 
meeting which was attended by more than 50 cardiologists. 
On the international stage SASCI was well represented at 
this year’s EuroPCR 2014 congress.
Annual SASCI Fellows Programme 
The 9th Annual SASCI Fellows Programme took place 
from 6 - 8 June 2014 at the Balalaika Hotel in Johannesburg 
with Chris Zambakides as programme convenor. Thirty 
two fellows/registrars and recently qualified cardiologists 
attended this popular workshop, including delegates from 
Mauritius and Angola. SASCI plans to develop the pro-
gramme for 2015 to further increase peer interaction and 
include even more case based discussions. SASCI wishes to 
thank Chris Zambakides (convener) and the faculty Farrel 
Hellig, Dave Kettles, Adriaan Snyders, Anthony Becker, 
Rafique Essop, Rashid Essop and JP Theron for their 
extensive contribution to the success of this long standing 
meeting. The following meeting sponsors are also gratefully 
acknowledged: Angio Quip, Aspen, AstraZeneca, Baroque, 
B Braun, Biotronik, Boston, Cardiac Output, Cordis, 
Medtronic, Paragmed, Pharma Dynamics, Sanofi, Torque 
Medical and Volcano. 
SA Heart Congress 2014 
Having started the year at full pace, we now have to keep 
up the momentum that we gained as we go into the latter 
half. True to form, SASCI actively supports the SA Heart 
Congress 2014 and contributes to the scientific pro-
gramme. Jean Vorster (SASCI) has been tasked to assist 
Sajidah Khan (SA Heart congress chairperson) in developing 
a focussed interventional programme. The international 
faculty will include a high-powered delegation from the 
European Society of Cardiology who will be hosting 2 
SOUTH AFRICAN SOCIETY OF CARDIOvASCULAR INTERvENTION
100 101
dedicated sessions at SA Heart. These sessions will include 
“hot messages” and “late-breaking clinical trials” from the 
2014 ESC Congress in Barcelona. SASCI members are 
invited to participate in a joint session with anaesthetists, 
surgeons and cardiologists called “Let the Team Meet” and 
to submit unusual or vexing clinical cases/images for the 
session entitled “Out of Africa - the weird and wonderful”.
Early Reperfusion STEMI
Lecture material is available and members should contact 
the SASCI office if they wish to get involved within regional 
educational initiatives. Adriaan Snyders is the SA Heart 
project leader and he is assisted by Dave Kettles for SASCI. 
Post Graduate Cardiology Training 
programme 
The society supports a Post Graduate Cardiology Training 
programme. The aim is to ensure that individuals receive 
exposure to high volume interventional units and also get 
the opportunity to observe and work with different 
operators, including surgeons, in the private environment. 
SASCI will establish a Task Group, with an open invitation 
to all Heads of Departments to participate, to form and 
drive this addition to interventional cardiology training in 
South Africa. 
ESC eLearning Platform 
Sajidah Khan is the South African national coordinator for 
the new ESC eLearning Platform. This programme focuses 
on web based Fellows training and offers training in 6 sub-
specialties with the first module being interventional 
cardiology. The duration of the EAPCI Learning Pro- 
gramme is 3 years (in addition to theoretical training there 
is a very specific interventional case mix requirement for 
certification). Although we do not have a candidate par-
ticipating yet, SASCI hopes that the first South African 
trainee will join this programme in the not too distant 
future.
RC Fraser International Fellowship 
The call for nominations for the 2014 RC Fraser Interna-
tional Fellowship has been distributed to all roll players 
and the next recipient, who will be able to spend one 
month at Dr Martyn Thomas’ unit in the UK, will be 
announced soon.
Executive members 
We express our sincere appreciation towards the com-
mitted Executive members who form the heart of this 
society: F Hellig (President), G Cassel (Ex-officio President), 
D Kettles (Vice-President), C Badenhorst (Treasurer), 
A Horak (Secretary), S Khan, M Ntsekhe, C Zambakides, 
M Abelson, L Steingo and J Vorster.
Corporate supporters 
The following loyal corporate supporters have been 
committed to our society and have been supporting edu-
cation in South Africa: Amayeza, Angio Quip, Aspen, 
AstraZeneca, Baroque, B Braun, Biotronik, Boston, Cipla, 
Cordis, Edwards, Logan Medical and Surgical, Medtronic, 
Paragmed, Pharma Dynamics, Sanofi, Scientific Group, 
Surgical Innovations, Terumo, Torque Medical, Volcano as 
well as Cardiac Output, Condor Medical and Disa Vascular. 
We are looking forward to continuing our collaboration 
with you.
please contact SASCI’s Executive 
Officer, george Nel at 083 458 5954 
or email sasci@sasci.co.za if you  
need any assistance or need to 
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PASCAR is an organisation (established in 1981) of physi-
cians from across Africa involved in the prevention and 
treatment of cardiovascular disease. PASCAR’s Governing 
Council consists of a core group of committed individuals 
with extraordinary knowledge of the African cardiovascular 
environment and the passion to make a difference.
In addition to our geographical aligned structures (North, 
East, South and West Africa), PASCAR Task Forces bring 
together representatives from key cardiovascular sub-
specialties such as interventional cardiology, life style risk 
modification and allied catheterisation laboratory pro-
fessionals. Professor Bongani Mayosi has stated that 
PASCAR will actively engage with Africa, North of the 
Sahara to become an active contributing region in PASCAR. 
This has culminated in the PASCAR 2015 Congress being 
awarded to the Tunisia Cardiac Society. 
pASCAr is currently involved in the following pro-
grammes:
“Cardiac pacing services for every African 
country”
There are 3 potential barriers to the establishment of an 
effective cardiac pacing service in Africa: The cost of 
pacemakers, lack of implantation facilities and absence of 
clinical expertise. The high cost of new pacemaker devices 
may be overcome by the re-use of pacemakers, a practice 
that has been demonstrated to be safe and cost-effective. 
Pacing requires the availability of x-ray equipment with 
fluoroscopic capabilities and aseptic conditions which are 
available in many hospitals in sub-Saharan Africa and in 
almost all academic centres. It is not necessary for the pro-
cedure to be carried out in a dedicated cardiac catheteri-
sation laboratory, a facility that is not available in the 
majority of African countries. Finally, the lack of trained 
doctors in pacemaker implantation and non-physician 
clinicians (or nurses) in supportive care is the only other 
significant barrier to the establishment of cardiac pacing 
in many countries in the region. African Fellowships in 
Cardiac Pacing and Clinical Cardiology addresses the lack 
of expertise through a 6-month intensive training pro-
gramme at high volume pacemaker implanting and training 
centre such as University of Cape Town, South Africa. 
Some North African countries could also act as training 
facilities. The first unit under this programme should be 
operational in Sierra Leone from mid-2015.
PASCAR brings together medical experts 
from across Africa: Convene to forge a path 
to eliminate rheumatic heart disease
A historic assembly took place at the Zambezi Sun, 
Livingstone, Zambia bringing together Africa’s leading 
experts in rheumatic heart disease (RHD) in order to 
design a roadmap for the control and elimination of the 
disease in Africa. The second Pan-African “Stop Rheumatic 
Heart Disease A.S.A.P in Africa” Continental Congress, 
being held under the auspices of the Pan African Society of 
Cardiology (PASCAR) and in partnership with Novartis, 
included cardiac specialists from more than 30 countries in 
Africa as well as representatives from the World Health 
PANAFRICAN SOCIETY OF CARDIOLOGY (PASCAR)
PASCAR National Council (Dakar, Senegal, may 2013)
from left to right - Back row: Dr Anastase Dzudie, 
Cameroon, Assistant Secretary general (Central Africa); 
Dr Harun Otieno, Kenya, Assistant Secretary general 
(East); Dr Saad Subahi, Sudan, vice-president (North); prof 
Elijah Ogola, Kenya, vice-president (East); Dr Awad 
mohamed, Sudan, Assistant Secretary general (North); 
prof Serigne Ba, Senegal, vice-president (West); prof 
Samuel Kingue, Cameroon, vice-president (Central); prof 
Johan Brink, South Africa, Assistant Secretary general 
(South). front row: prof Toure Ali Ibrahim, Niger, Assistant 
Secretary general (West); Dr Ana-Olga mocumbi, 
mozambique, vice-president (South); prof Bongani mayosi, 
South Africa, president; prof Karen Sliwa-Hahnle, South 
Africa, Treasurer; Dr Benedict Anisiuba, Nigeria, Secretary 
general. Not in picture: prof patrick Commerford, South 
Africa (Editor, Cardiovascular Journal of Africa).
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 ■  Implementation plan with the use of the World health 
organisation-Africa policy,  
 ■  Monitoring, evaluation and regular revision. 
PASCAR educational collaboration in 
Catheter Laboratories of Africa
The South African Allied Group Society, ISCAP (The 
Interventional Society of Cath Lab Allied Professionals) 
donated a complimentary copy of their recently published 
Cardiac Catheterisation Training Manual to every cath lab 
unit in Africa. This will be the first of hopefully many more 
collaboration opportunities in this cardiac environment. 
PASCAR task force on nutrition and 
cardiovascular diseases
This new initiative was launched in June 2014 and will 
consist of a situational analysis on nutrition and CVD in 
Africa as well as stakeholders’ consultation and systematic 
reviews of published data (including data meta-analysis). 
The task force will issue stakeholders’ consultation report, 
peer-reviewed publications, guidelines on lifestyle manage-
ment to reduce CVD risk in Africa and a handbook on 
nutrition and CVD in Africa. Evidence will be gathered 
from the cross country project and a multi-country, school-
based programme with eventual communication through 
the PASCAR website, social media and a Satellite sym-
posium in Tunisia (September 2015).
Medical Society Management 
PASCAR has recently appointed Medical Society Manage-
ment to assist the society with an office and management 
infrastructure. This allows the Governing Council to focus 
on identifying key issues, brainstorm novel solutions and 
design appropriate programmes to combat cardiovascular 
disease across the continent. The PASCAR office focuses 
on liaising with stakeholders and the successful imple-
mentation of priority programmes. The level of additional 
resource required is determined by the specific programme 
and is funded by third parties with mutual interests. 
PASCAR is forming working relationships with other 
organisations and departments with a similar mandate and 
focus in Africa. 
please contact pASCAr at george@medsoc.co.za or 
www.pascar.org.
Organisation (WHO), the African Union Commission 
(AUC) and the World Heart Federation (WHF). “The time 
is now to scale up our efforts if we are to realise the 
elimination of rheumatic heart disease in Africa in our 
lifetime,” said Prof Bongani Mayosi, a leading advocate 
for patients with RHD globally. The meeting took place 
from 31 January - 4 February in Livingstone, Zambia. The 
Zambian Minister of Health gave the opening address, 
welcoming the 50 delegates from over 20 countries from 
across Africa, Cape to Cairo. “Despite its high prevalence, 
for a very long time rheumatic heart disease has been a 
neglected disease in Africa, but this is slowly changing,” 
said Dr John Musuku, paediatric cardiologist at the 
University Teaching Hospital in Lusaka, Zambia. Under 
the auspices of PASCAR and in partnership with Novartis, 
Dr Musuku is leading a broad effort in Zambia to measure 
the prevalence of RHD in school children and to create a 
new electronic patient registry. The other delegates are 
working in all areas in Africa, leading important new 
research in RHD contemporary measures as well as the 
genetic epidemiology of RHD – the REMEDY study and 
RHDGen represents the start of a new era in ground-
breaking RHD research in Africa.
PASCAR task force on hypertension
PASCAR embarked on a process to write, disseminate, 
implement and monitor a very practical guideline towards 
the management of high blood pressure in Africa. High 
blood pressure (BP) is the most common single risk factor 
for cardiovascular related events and deaths worldwide. 
Over the last years, a substantial number of publications 
have highlighted the growing evidence of high BP as a 
largely underdiagnosed and undertreated disease associated 
with poverty and ignorance, henceforth leading to 
complications like stroke, kidney disease and heart failure. 
Recently, under the high patronage of the Senegalese 
president, as the leading continental organisation, PASCAR 
has engaged and adopted “The 10 Best Buys” to combat 
heart disease, diabetes and stroke in Africa with hyper-
tension management as the first priority. PASCAR has 
not only taken a real measurement of the condition and 
the challenges but also the opportunities that exist in 
developing a credible preventive programme with the 
following elements: 
 ■  Clinical and very practical guidelines that answer the 





W e have once again reached the “conference season” time of the year and SASCAR and many of its members have been, or will be 
involved in different national and international meetings 
over the next few months. In this newsletter it is thus our 
pleasure to report on some of them:
Joint ISHR/SASCAR session at the ESC 
Frontiers in Cardiovascular Biology Meeting, 
Barcelona, Spain from 3 - 6 July 2014
For the first time, a joint session between the International 
Society for Heart Research (ISHR) and SASCAR formed 
part of the programme at the basic cardiovascular research 
meeting which is organised by the ESC every 2 years. Six 
members of SASCAR attended and presented their 
research at this exciting meeting: Sandrine Lecour, Barbara 
Huisamen, Hans Strijdom, Gerald Maarman, Sarah Pedretti 
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at the SA Heart Association Congress
SA Heart Congress 2014 will be held in Durban, from 16 – 19 October, with the central theme being ‘Bridging the Divide’. This is 
the divide that exists between current best practice – and the challenges encountered in implementing these ideals. All medical 
and allied professionals with an interest in cardiac health are warmly invited by the organising committee to attend. 
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15th Annual SA Heart Congress, Durban from 16 - 19 October 2014
This year’s meeting, with the theme: “Bridging the Divide”, will boast no less than 3 
basic sciences sessions, the most in recent years! Prof Rainer Schulz, from Giessen, Germany, 
will be a SASCAR-invited member of the international Faculty of SA Heart 2014. Other 
speakers invited by SASCAR include Faadiel Essop (University of Stellenbosch) and Carola 
Niessler (University of KwaZulu-Natal). Please visit http://www.saheartcongress2014.co.za/ 
for more information. The SASCAR basic sciences sessions will be a combination of invited lectures and selected abstract 
presentations. Here are some of the scientific programme highlights of the basic sciences sessions:
and Corli Westcott. In addition, Sandrine Lecour was an 
invited speaker at the ISHR pre-symposium and Hans 
Strijdom served as a session chair. 
RAAS Satellite Meeting 2014, Spier Estate, 
Stellenbosch from 11 - 12 July 2014
Emerging Trends in the Pharmacology of drugs for hyper-
tension and heart failure with a special focus on the RAAS 
were the central themes at this meeting which was held at 
Spier, 11 - 12 July 2014. This meeting, which was orga-
nised by Prof Edward Sturrock, was endorsed by SASCAR, 
HeFSSA and the University of Cape Town. A large number 
of national and international prestigious guest speakers 
were invited for an exciting programme. The invited 
Faculty of the meeting included many SASCAR members: 
Neil Davies, Sandrine Lecour and Karen Sliwa. For more 
information, visit the website: http://raassatellite2014.org
SOUTH AFRICAN SOCIETY FOR CARDIOvASCULAR RESEARCH (SASCAR)
FRIDAY 17 OCTOBER, SASCAR PARALLEL SESSION 
   CARDIAC PROTECTION
13h30 - 13h55 Anti-platelet therapy in acute coronary syndromes: from bench to bedside
  Rainer Schulz
13h55 - 14h20 Anaesthetics and cardioprotection
  Justiaan Swanevelder (UCT)
14h20 - 14h40 HDL therapy for cardioprotection
  Sandrine Lecour (UCT)
14h40 - 15h00 phosphatases and cardioprotection
  Derick Van Vuuren (US) 




SASCAR member Balindiwe Sishi (University of Stellenbosch) was recently recognised in the Mail & Guardian 
newspaper when a feature appeared on her scientific achievements as part of the newspaper’s “200 young South 
Africans 2013” series.
Research grant 
Hans Strijdom was recently awarded a multi-million Rand research grant for a clinical study on the association between 
HIV-infection, antiretroviral treatment and endothelial dysfunction in Sub-Saharan African populations. The study 
proposal, of which Strijdom is the coordinator, was submitted to the ERAfricaproject as part of the European 
Commission’s 7th Framework Programme for Research. The research consortium 
consists of researchers from South Africa, Kenya, Côte d’Ivoire, Belgium and 
Austria and the study will initially run for 3 years.
SATURDAY 18 OCTOBER, SASCAR PARALLEL SESSION 
   BASIC SCIENCES
11h00 - 11h30 protease inhibitors induced cardiometabolic dysfunction
  F Essop (US)
11h30 - 12h00 TBA
  Angela Woodiwiss (Wits)
12h00 - 12h15 Selected abstract
12h15 - 12h30 Selected abstract
  STEM CELL THERAPY
13h30 - 13h55 Stem cell therapy for cardiac repair: hype or hope?
  B Gersh
13h55 - 14h20 Stem cell therapy: an African perspective
  C Niesler (UKZN)
14h20 - 14h45 Delivery mode for stem cell therapy
  N Davies (UCT)
14h45 - 15h00 Selected abstract
15h00 - 15h15 Selected abstract
sa heart
106 107
S ince the SA Heart executive tasked the SHARE committee with the design of a new sustainable registry, the committee has met several times and 
has taken the input and the experience gained with the 
first phase of SHARE to help mould SHARE II into 
something a little different. In the first phase of SHARE we 
envisioned one national cathlab registry which aimed to 
capture highly detailed clinical information at every cathlab 
in the country on an ongoing basis, as a snapshot of 
what is being seen in the cathlab. We also had a surgical 
registry which covered adult and paediatric cardiac surgery, 
and thoracic surgery in great clinical detail, with signifi- 
cant overlap in the data elements between cardiology 
and surgery.
It was not financially viable to continue with this model as 
it became significantly more expensive as more participants 
came online. Some participants were also reluctant to 
capture this highly detailed information on a seemingly 
never-ending basis for every patient coming through 
cathlab. The committee has also heeded past comments 
from members regarding the paucity of follow-up data in 
the registry, which has reduced the usefulness of the data 
for research to some extent. Following consensus from 
the vast majority of participants, it was decided to close 
down the data collection for both surgery and cardiology 
and end phase one of the SHARE data collection.
To overcome these issues in the second phase of SHARE, 
the committee decided to structure SHARE II on a “per-
project” basis and has set out some guidelines about 
participation in SHARE II relating to number and type of 
centres participating in each project, to ensure that we 
have a database that is reflective of practice in South 
Africa. While SA Heart will continue to contribute towards 
the running of the centralised SHARE office and will 
provide access to a centralised database platform through 
an approved developer, all projects will be responsible 
for raising their own funding for database development 
and project management and each must obtain Ethics 
Approval. The SHARE office will assist with this and provide 
guidance in each project where needed as part of the 
centralised service offered by SHARE. 
The second phase of SHARE will run projects set up 
according to a model of clinical trials and anyone who 
wants to approach SA Heart to run a project, within the 
SHARE fold, will be able to obtain an Expression of 
Interest form from the SA Heart Website. Following the 
receipt of the Expression of Interest form, the SHARE II 
committee will review the application, and if the aims of 
the project align with the SHARE II objectives, first and 
foremost of which is improving patient care, the interested 
parties may then proceed to submit a protocol according 
to the guidelines which will be forwarded to them.
Each project must have a champion fulfilling the same role 
as a Principal Investigator in a clinical trial so that the 
projects are directed and driven by someone who is 
passionate about what they are doing. In addition the PI 
will, again with the help of the SHARE office, be instru-
mental in motivating other centres to participate. All par-
ticipation will be voluntary and entered into with written 
commitment for the term of the project, which will be 
clearly defined from the beginning. The SHARE committee 
believe that only if our members take ownership of a 
project and the data collection, and have a clearly defined 
SHARE REGISTRY
Each project  
must have  
a champion 
fulfilling the  
same role as a 
Principal 
Investigator in  
a clinical trial.
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project goal (which includes publication and presenta-
tion of the results of the study) will SHARE II be able to 
fulfil its aim of providing high quality research data for 
use by our community to improve standards of practice 
and patient care.
SHARE II has already been approached and has accepted 
proposals from 2 groups to run projects within SHARE. 
The data collection in both of these cardiology projects 
will be officially launched at the SA Heart Congress in 
Durban in October and they are already in the develop-
ment phase with the software developer. Through 
negotiations by the SHARE Project manager with the 
software provider, e-MD has graciously allowed the 
existing surgical registries on the phase I SHARE e-MD 
platform to be used by the UFS at no charge 
for a period of a year. These registries will now be run 
by the SCTSSA and future development of surgical 
registries will be spearheaded by this SIG. 
SHARE II is a SA Heart platform and resource that is 
available to all our members – surgeons, cardiologists, 
medical scientists and industry. While further projects 
are already being contemplated for the end of the year, 
we invite our members in Industry and academia to 
look to the SHARE infrastructure for future project 
collaborations, particularly with the surgeons. 
If you are interested in using the SHArE II 
platform for a project, please contact  
Elizabeth Schaafsma at 083 603 7700 or  
email elizabeth@vodamail.co.za  
for further information.
Are you pASSIONATE about SA Heart,  
Co-Operation, Teamwork 
And do you like to WrITE, mOTIvATE  
and fACILITATE
And INfLUENCE the cardiology community?
Then we have a CHALLENgE for you…
Apply to take on the responsibility as  
Editor of SA Heart Newsletter




SASCI www.sasci.co.za I CASSA www.cassa.co.za I SA Heart www.saheart.org I HeFSSA www.hefssa.org
ACC www.acc.org I Research (SASCAR) www.sascar.org.za I ESC www.escardio.org




I had the opportunity to attend the Frontiers in Cardio-Vascular Biology 2014 meeting in Barcelona (Spain) from the 4 - 6 July.
3 July 2014
I attended the ISHR pre-symposium which offered several 
sessions including novel aspects in cardio-protection (a 
joint session with SASCAR), mito-chondria and cardio-
vascular disease, GPL-1 and the heart, multiple pathways to 
cell death; followed by the young investigator award 
session. The day concluded with the moderated poster 
session. 
4 July 2014 
The day started with an interesting keynote lecture on the 
2 pathways of translational cardiovascular research: The 
next decade. This was followed by several sessions inclu-
ding atheroprotective mechanisms of HDL, Scientist of 
tomorrow: New pathway for basic research and longevity. 
Throughout the day I looked at several really interesting 
studies in the poster area which covered different topics 
like ischaemia/reperfusion, atherosclerosis and signalling.
5 July 2014 
The day started with interesting sessions on frontiers in IPS 
technology and coronary microvasculature remodelling, 
followed by a keynote lecture on IPSCs for cardiovas- 
cular diseases. The young investigators competition, which 
featured great quality speakers, took place in the afternoon.
6 July 2014 
The last day started with sessions on miRNA functions in 
atherosclerosis and vascular biology as well as RNAs on 
cardiovascular medicine. During the lunch break I had 
the opportunity to present my results in the poster area. 
I received a lot of feedback on my work and some great 
ideas for my future research. This was a highlight for me 
as I had the opportunity to discuss my work with well-
known scientists.
I am grateful to the SA Heart which awarded me the SA 
Heart-Cipla Travel Scholarship.
REPORT ON FCvB 2014 BY DR SARAH PEDRETTI
Dr pedretti displaying her poster
prof Sandrine Lecour, mr gerard maarman and Dr Sarah 
pedretti (from the Hatter institute) enjoying a moment at 
the CvB in Barcelona.
I am  
grateful to the  
SA Heart.
108 109
from left to right: Dr philip Herbst, professor Anton 
Doubel and Dr Alfonso pecoraro in the newly completed 
Echo in Africa training and research center at Tygerberg 
Hospital.
Echo in Africa (EIA) is a joint venture of the British Society 
of Echocardiography (BSE) and SUNheart, a not for profit 
foundation of the University of Stellenbosch, residing in the 
division of cardiology at Tygerberg hospital. 
This exciting project has at its core 2 important objectives. 
The first is humanitarian in nature and will provide for an 
echocardiography screening programme aimed at searching 
for early signs of heart disease (including rheumatic heart 
disease) amongst 2 000 school children in Ravensmead 
and Khayelitsha and providing for aftercare of any affected 
individuals identified through screening. In addition, a 
research arm of the project will test important hypotheses 
related to the echocardiographic screening for rheumatic 
heart disease. The concept of pre-screening will be formally 
assessed and important questions around the importance 
of morphological versus functional aspects of currently 
used echocardiographic screening criteria will be asked, to 
name but 2.
The project will take place in a purpose renovated training 
and research center recently completed and situated 
adjacent to the cardiology ward in Tygerberg hospital. The 
facility makes provision for 12 echocardiography scanning 
stations that can be occupied and run simultaneously. The 
12 stations are networked to the TBH cardiology imaging 
archive and network system (GE ECHOPAC) and this 
provides for effective storage, review and post analysis of 
echocardiography studies. In addition, a research facility 
with viewing and review stations for data analysis complete 
the working end of this state of the art facility. 
The project takes place over an 8 week period spanning 3 
months and kicks off on 28 July 2014. It is supported by 
close to 100 experienced BSE accredited sonographers 
from the UK. This amazing group of individuals has taken 
on and successfully completed a fundraising initiative in the 
UK in support of the project. Approximately 2 000 high 
school learners from 4 schools in the Ravensmead and 
Khayelitsha areas of Cape Town will be screened in the 
first year of the project and the support and enthusiasm 
from the learners, schools and parents for this project has 
been overwhelming. Echocardiography based research on a 
large scale is expensive, labour intensive and time con-
suming. It is hoped that this programme will be a blueprint 
for future large scale echocardiographic research based on 
this format. It is planned that the current Echo in Africa 
programme will run for a 5-year period. The Echo in Africa 
project is fully endorsed by SA Heart.
Dr Philip Herbst
Consultant Cardiologist
University of Stellenbosch and Tygerberg Hospital
ECHO IN AFRICA: THE SEARCH FOR RHEUMATIC HEART DISEASE




Let’s unite in the fight against salt
South Africa has one of the highest rates of high blood 
pressure in the world. In fact, one in 3 adult South Africans 
are living with high blood pressure which is one of the 
leading causes for heart disease or stroke. Every day 225 
people die from heart disease, 76 of them due to a stroke. 
An estimated 10 people will suffer a stroke and 5 people 
will have a heart attack every hour! The link between salt 
and high blood pressure is well-documented, but on 
average, South Africans are consuming more than double 
the recommended amount of salt! These statistics alone 
highlight the dire need for the Salt Watch awareness 
and education campaign which aims to encourage South 
Africans to eat less salt. The Heart and Stroke Foundation 
South Africa is calling on you to unite with us in the fight 
against salt.
Regulation alone isn’t enough
South Africa is considered to be a world leader because 
globally we are the first country to regulate salt content 
across a wide spectrum of foods. However, regulations 
alone will not be sufficient; South Africa needs education 
and health promotion efforts as well. Forty percent of salt 
consumed in South Africa is discretionary salt, which is 
added during cooking and at the table. Furthermore, 
according to a recent study presented at the Salt Summit 
on 13 March 2014, researchers found that nearly a fifth 
of consumers compensated for a reduced salt meal (pre-
pared by a reduced salt stock cube) by adding salt back 
into the meal, even to the point of overcompensation. 
Thus education and heightened awareness is necessary in 
order to bring about behavioural changes and to reduce 
salt intake.
How will the regulations 
affect the people of South 
Africa?
A recent study calculated the potential 
impact of these salt reduction targets 
in a cohort of South African adults. 
Achieving the salt reduction targets set by the National 
Department of Health of less than 5g of salt per day per 
person would translate to an average of 2.9g to 3.3g per 
HEART AND STROKE FOUNDATION SOUTH AFRICA
day lower salt intake per person. These targets are 
estimated to: 
 ■  Reduce CVD deaths by 11%, averting 3 363 deaths 
and 6 563 new cases of CVD per year in the general 
population;
 ■  Amount to an annual household saving of R42 million 
in healthcare costs, mostly among middle-class fami-
lies; and
 ■   Save the government approximately R536 million a 
year in health care subsidies alone.
We need your help
Research has shown that people view the medical 
community as a trusted source of information. We there-
fore call on all medical practitioners to partner with us to 
help win this fight by spreading the same consistent 
messages regarding the dangers of too much salt. 
In support of the public awareness campaign, we need the 
help of medical practitioners to get the following key 
messages across to the public:
 ■  Too much salt increases blood pressure, which causes 
heart attacks and strokes.
 ■  Many South Africans consume too much salt, up to 
twice the recommended amount.
 ■  The foods that we buy already contain a lot of salt, so 
we can use less salt at home while cooking and at the 
table.
Lights, camera, action!
A crucial element of the Salt Watch campaign is adverti-
sing – fortunately the National Department of Health 
sponsored R5 million towards this. The campaign aims to 
utilise radio and television as key channels to reach the 
majority of South Africans to educate them about the 
dangers of eating too much salt and to encourage them 
to eat less salt. The adverts are scheduled to air from mid-
July, so keep an eye out for them!
What about “hidden” salt?
Up to 55% of the salt we eat comes from processed foods!
In South Africa, the top contributors to daily salt intake are:
 ■  Bread (all types)
 ■  Processed meat products
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 ■  Eating out – restaurants are notorious for creating salty 
meals, as this is an easy way to boost flavour. Ask your 
waiter to tell the chef to use less salt in your meal, and 
if the dish has a sauce or dressing, ask for this to be 
served on the side.
Useful resources
The table below can help your patients decide if a food is 
low, moderate or high in sodium. Show them how to look 
at the amount of sodium per 100 g of food and not per 
serving, which is found in the Nutritional Information Table 
on the packaging.
Lending a helping hand
The HSF has several resources that may be helpful in 
assisting and encouraging your patients towards adopting 
heart-healthier lifestyles. 
for more information, please contact 021 447 6268, 




You can also refer your patients to our Heart and Stroke 
Health Line – 0860 1 HEART (43278), where they can 
speak to one of our health consultants.
Dr vash mungal-Singh 
Chief Executive Officer
Heart and Stroke foundation SA (HSf)
 ■  Soup/gravy powder 
 ■  Meat and vegetable extracts
 ■  Hard/block margarine 
 ■  Savoury snacks (including crisps)
 ■  Breakfast cereals.
Tips to eat less salt
You can use these handy tips to help your patients eat less 
salt – especially those who already have high blood 
pressure.
 ■  Cut down on processed foods – salt is found in almost 
every pre-prepared food, from processed meat to 
canned soup, to bottled dressings and packaged sauces, 
bread and condiments such as ketchup and pickles. Try 
to use more fresh foods and less processed foods.
 ■  Cook at home – preparing your own meals means that 
you can control how much salt you add as well as 
increasing the quantity of vegetables you add to dishes. 
Taste your food during cooking before you add salt, as 
it may not need it. If you have already added salty spices 
or a stock cube, you don’t need to add salt too. If you 
used salt during cooking, you don’t need to add more 
at the table. Don’t put the salt shaker on the table. This 
will help stop the habit of adding salt to your plate.
 ■  flavour your food – but don’t use salt. Choose fresh or 
dried herbs, spices, garlic or lemon juice to ensure that 
your food doesn’t taste bland.
 ■  read the list of ingredients – if sodium or salt is listed 
in the first 3 ingredients, the food is likely to be a high-
salt choice. Salt may also be “hidden” on the list as 
table salt, sodium chloride, monosodium glutamate 
(MSG), sodium nitrate, sodium bicarbonate and soy 
sauce – these are all salt as well! 
 ■  Read the label – some products may have a low salt, 
low sodium or no salt added version, but also be aware 
that these products may not necessarily be ‘healthy’ if 
they are also high in sugar or fat. 
 ■  Look for the Heart Mark - choose foods with the Heart 
Mark logo as these products have less salt (sodium) 
compared to similar products. 
sa heart
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A s you are aware the SASCI STEMI Early Reper-fusion project started in the Tshwane (Pretoria) region. This project focuses on STEMI as the 
diagnosis and management and is well defined and 
supported by evidence based studies. Although this project 
focuses on STEMI patients, which form a minority of acute 
coronary syndrome (ACS) patients, I am optimistic because 
the side effects of establishing good education, networking 
and capturing data will also benefit all other ACS patients. 
These 3 focus areas are detailed further below:
Education
Education starts at cathlab hospitals and is intended for 
nursing staff, allied professionals, emergency room doctors, 
specialists as well as hospital staff and managers. Educa-
tional activities are then launched in hospitals without 
cathlabs, emergency rooms found in other city hospitals, 
referring general practitioner groups and other referring 
suburban centres. We also try to include as many as 
possible emergency medical services (EMS) staff members, 
general practitioners, physicians, managers, nursing staff 
and anyone else who may be part of the process. Finally 
we intend to start a patient awareness programme through 
the Heart and Stroke Foundation (HSF). While these 
sessions focus on STEMI management, they also open up 
educational possibilities to all other aspects of the acute 
coronary syndrome (ASC) patient, therefore benefiting an 
even larger group of patients.
Networking
Establish a network to ensure proper transport of the 
patient to effective medical care. This will most likely assist 
all other ACS patients in obtaining appropriate care.
Research/Registry with follow up to ensure 
outcome data
Data for the South African population either does not exist 
or is frowned upon as the accuracy of the data is often not 
validated directly from the source.
Although it has taken some time to get the various stake-
holders to start collaborating on improving care for acute 
myocardial infarction (AMI) patients in the Tshwane region, 
we are making progress. We are slowly identifying the 
responsible doctor in each cathlab and fostering commit-
ment to the project. We continue our work towards 
obtaining permission from the various hospitals to start 
the registry as soon as possible. We learnt in our pilot 
project that without buy in from hospitals and the hospital 
groups, the registry will not succeed. We do however plan 
on running a 2 months survey during the second part of 
2014 but need to ensure that the hospitals are educated 
and prepared to enthusiastically support the capturing of 
data. Furthermore, in order for ethics approval to be given, 
we need to obtain permission from the respective cathlab 
hospitals. In the interim I have met with Dr Ashley 
Chengadoo from Netcare but was not yet able to meet 
with Dr Lloyd Kaseke from Life Healthcare. Dr Tom Mabin 
will meet with Mediclinic to obtain their support for the 
survey. We have also completed the last GP educational 
meetings and plan a second round of meetings in 2015. 
Due to the success of the project in the Tshwane region, 
we have now reached the stage of national roll out. In 
order to drive the project forward a steering committee 
(as listed below) has been formed:
Dr Adriaan Snyders National Coordinator
Dr David Kettles  SASCI Representative and 
Coordinator Eastern Cape
Dr Sajidah Khan  Coordinator KwaZulu-Natal  
and assisting in research survey 
registry
prof rhena Delport Research/registry
Amy Wolfe Education material and literature
george Nel (mSm) Finances and Logistics
Dr Len Steingo  Coordinator Johannesburg  
North and West
Dr Chris Zambakides  Coordinator Johannesburg  
South and East
Dr Tom mabin  Coordinator Western Cape; 
collaboration with HSF and 
patient awareness
SASCI STEMI EARLY REPERFUSION 
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on ambulances are suitable. There are also discussions 
with industry members concerning the development of 
an electronic registry and other aspects of our 
programme.
 ■  The educational activity in Mosselbay and the Eastern 
Cape has been driven by the enthusiasm of ISCAP. 
Until now we have not received any requests for 
assistance from any other regions. A priority focus of 
the project in the next 6 months will be the esta-
blishment of effective communication with govern-
ment. We would like to see the regions well prepared 
before we embark on a patient awareness campaign. 
However, we may need to consider public pressure 
from patients for improved care if healthcare continues 
to ignore their responsibility.
 ■  I met with Dr Lara Goldstein, Head of the Emergency 
Department and Helen Joseph Hospital, which is the 
first public Hospital indicating interest to participate 
in our project. It seems that rather than wishing or 
begging for public hospitals to participate, we will assist 
hospitals who want to participate voluntarily and who 
are able to identify a person to take responsibility for 
that hospital.
Dr Shirley middlemost  Western Cape and education 
material
Although the national roll out is still in its infancy, a number 
of key steps have already been taken:
 ■  The following industry members have funded the 
programme thus far: Axim, Boston, Aspen, Baroque, 
Angio Quip, Amayeza and Pharma Dynamics, with 
pledges received from Edwards, Medtronic, Biotronik, 
Boehringer, Torque Medical and B Braun. 
 ■  Prof Rhena Delport assisted with a report for Stent for 
Life (SFL) to be published in a supplement of Euro-
Intervention as part of a paper that describes the 
opportunities and challenges in building STEMI systems 
of care in SFL-affiliated and collaborating so-called 
emerging countries, namely India, China, South Africa 
and Mexico.
 ■  Dr Sajidah Khan represented us at a SFL working dinner 
during the EuroPCR 2014 congress.
 ■  I have started to meet with the EMS in the Pretoria 
region, although it has proven to be a daunting task. In 
Pretoria there are 24 different EMS but only 2 are 
capable of appropriately transporting and caring for 
myocardial infarctions namely Netcare and ER24. We 
still have limited information on the status of public 
health EMS. 
 ■  I met with Willem Stassen from ER 24, Chief Fire Medic 
and head of ER 24 Research Committee. He is one of 
180 emergency medicine medics with a degree in 
emergency medicine and qualified to give thrombolytic 
medicine. Many of these 180 medics are involved with 
training and management and some are contracted to 
work elsewhere in Africa. He is presently working on 
his doctorate evaluating resources and efficacy of 
managing STEMI patients. This is a huge task and in line 
with our project. I offered our assistance with training 
in STEMI and explained our strategy of developing a 
network/team to effectively manage not only STEMI 
patients but all patients with cardiac chest pains.
 ■  I am consulting with some industry partners to develop 
effective ECG diagnosis and to ensure that ECG units 
Continued on page 114
We are slowly 
identifying  
the responsible 




to the project. 
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 ■  I am in the process of making contact with Stent India. 
India launched a very successful programme and has 
already had 2 2-day courses which were not only 
attended by physicians but all other members of the 
network including participation and active involvement 
from their government. I envision developing a similar 
programme and inviting them to South Africa. Please 
visit their website: www.stemiindia.com
From an international perspective, we continue to learn 
about challenges that other countries have faced and how 
they have managed to overcome these hurdles. India has 
started a very successful programme in certain provinces 
and one of the key contributors to their success has been 
the involvement of the Indian government. In order to 
highlight the importance of managing AMI patients, India 
STEMI held a weekend symposium involving the govern-
ment. Delegates included doctors, EMS and hospital staff 
with the focus of the meeting being on upskilling and 
the development of a network monitored by an effective 
registry to which all physicians had to contribute. The 
success of this project can be attributed to the involvement 
of government. In the South Africa setting, our fragmented 
medical services are a challenge but should not make an 
effective network impossible. 
Another key step to improving AMI patient care in India 
has been the development of a PC based ECG which is 
installed in ambulances and which immediately sends the 
patient’s ECG to the doctor on call. Local government, in a 
few Indian provinces, has also taken out and continues to 
pay for medical insurance for all registered inhabitants who 
do not have access to private health care to ensure that 
every STEMI patient will be covered for transport to a 
cathlab center and consequent effective treatment. If India 
has been able to implement such a successful system, there 
is no reason that South Africa cannot follow suit. I have 
made contact with the India STEMI project to investigate 
the possibility of learning from their programme and maybe 
work towards a similar symposium in South Africa in 2015. 
Effective/Correct Diagnosis that lead to correct/Effective 
Management is Cost Effective at any price while Ineffective/
incorrect Diagnosis and or Incorrect/ineffective Manage-
ment is expensive at any price.
All readers are invited to contact their local SASCI group 
or myself for further information but also to contribute 
with your participation. We have educational material, a 
poster available and you are also invited to contribute to 
our educational library which is managed by Amy Wolfe.
Adriaan Snyders
asnyders@mweb.co.za
SASCI STEMI EARLY REPERFUSION CONTINUED






THE SOUTH AFRICAN HEART ASSOCIATION
RESEARCH SCHOLARSHIP
The research scholarship is available to all full and associate members of SA Heart Association living in South Africa. It 
is primarily intended to assist colleagues involved in much-needed research to enhance their research programmes.
REqUIREMENTS
■  Applicants need to be fully paid-up members/associate members in good standing for at least one year.
■  Applications must include
	 ■	The applicant’s abbreviated CV;
	 ■	A breakdown of the anticipated expenses;
	 ■	Ethics approval; and
	 ■	Full details of the research.
RECOMMENDATIONS
■  Publications of related work in a peer-reviewed journal in the preceding year;
■  Applicants from a previously disadvantaged community; and
■  Applicants younger than 35 years of age.
APPLICATIONS MUST BE ADDRESS TO:
Education Standing Committee




And submitted to the SA Heart Office electronically: erika@saheart.org
THE SELECTION PANEL WILL REvIEW APPLICATIONS ANNUALLY AND THE CLOSING DATE  
IS 30 SEPTEMBER.
One scholarship to a maximum amount of R50 000 will be awarded annually.
APPLICATIONS WILL BE ASSESSED ACCORDING TO THE ACCOMPANYING RESEARCH 
PROTOCOL WHICH SHOULD INCLUDE:
■ An abstract (maximum 200 words);
■ A brief review of the literature (maximum 200 words);
■ A brief description of the hypothesis to be investigated (maximum 100 words);
■ A detailed methodology (maximum 500 words); and
■ References.
Members who have received this scholarship in the past 3 years need not apply.
sa heart
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H istorically the medical device industry has sponsored healthcare professionals to attend both local and international congresses as well as 
sponsoring the event itself. In the past congresses were 
often held at exotic venues like beach and ski resorts or on 
luxury cruise ships. While attending the congress, some 
doctors received 5 star treatment which included champagne 
breakfasts, trips to the theatre, skiing excursions or games 
of golf. Although the majority of time spent at a congresses 
focused on educational content, a significant amount of time 
was also spent on entertainment. However, this is a thing of 
the past. Of late professional bodies like the American 
Medical Association (AMA), American College of Cardiology 
(ACC) and many other organisations and bodies in the USA 
and other western countries have introduced punitive 
measures which ban doctors from accepting favours in cash 
or kind from the industry. 
Certain countries have also decided to introduce legislation 
in order to curb this behaviour. Chief among these is the 
Foreign Corrupt Practices Act and the Physician Payment 
Sunshine Provision (Sunshine Act) in the USA. Passed in an 
effort to allay concerns about conflicts of interest between 
physicians and the pharmaceutical and medical device 
industries, the Sunshine Act requires manufacturers of 
drugs, devices, biologicals and medical supplies to record all 
payments to physicians. The goal of the law is to enhance 
patient safety by increasing the transparency of financial 
relationships between health care providers, pharmaceutical 
and medical device manufacturers. 
Inspired in part by this law, France passed its own Sunshine 
Act in 2011, as well as Slovakia, which passed several 
amendments that subject health care companies to certain 
restrictions and requirements regarding their relationships 
with medical practitioners. The European Federation of 
Pharmaceutical Industries and Associations (EFPIA) repre-
sents 33 European national pharmaceutical industry asso-
ciations and requires its members to publish reports 
detailing any financial support.
Industry organisations in Australia and the Netherlands have 
adopted similar measures requiring health care companies 
to publicly disclose financial relationships with medical 
professionals, while a professional association in Japan also 
requires that members implement specific transparency 
policies. 
Advamed (the American Medical Device Industry Associa-
tion) has amended its code and now prohibits direct 
sponsorship of healthcare professionals to attend local and 
international congresses. The Advamed Code also prohibits 
the giving of gifts to healthcare professionals. This was a 
key topic of discussion at the recent International Medical 
Device Compliance Conference which Tanya Vogt, Exe-
cutive Officer of the South African Medical Device Industry 
Association (SAMED), attended. Vogt states: “We are 
seeing more countries e.g. Sweden moving toward restric-
tions on direct sponsorship and Denmark implementing 
onerous requests and reports that healthcare professionals 
must complete prior to receiving product related training”. 
Vogt further believes that asking the industry to completely 
divorce itself from the profession in terms of sponsorship of 
congresses and support for ongoing medical education is 
not a good idea. The medical device industry relies on the 
profession to provide valuable input towards new and 
innovative product development and the profession in turn 
relies on the industry to provide invaluable product training 
and sponsor the cost of congresses which helps defray 
some of the operating costs of their societies. However, 
there is no denying the fact that greater transparency is 
required in relation to industry funding of congresses and 
continued medical education. Vogt reiterates that “It is no 
longer a case of whether to, but when!”
Due to the fact that their parent companies are based in 
the USA or Europe, a number of SAMED members are 
also subject to adherence to the afore-mentioned interna-
tional codes and legislation. For South African medical 
device companies this means different rules for multinational 
versus local entities and it makes it difficult to level the 
playing fields.
In the absence of similar legislation, countries like South 
Africa rely on industry-developed codes of conduct. The 
INDUSTRY SUPPORT FOR MEDICAL CONGRESSES AND CONTINUED 
MEDICAL EDUCATION – INTERNATIONAL AND LOCAL TRENDS
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Marketing Code of South Africa, to which SAMED members 
subscribe, offers clear guidelines regarding support by the 
industry for local and international congresses. The Code 
states that the healthcare industry should refrain from giving 
the incorrect impression about the industry to other stake-
holders including patient and consumer associations, the 
press, healthcare professionals, government officials and 
also the general public by offering excessive hospitality that 
could harm the industry.
The Code clearly sets out rules regarding international and 
local travel, venues, meals, accommodation, hospitality and 
entertainment. For example, companies may only sponsor 
business class travel for faculty members presenting at a 
congress and Healthcare Professionals attending advisory 
boards and clinical investigations. It is also not appropriate 
to pay for travel expenses for guests or spouses/partners of 
Healthcare Professionals or for any other person who is not 
a trainee or an invited attendee to such a meeting. Travel 
should be arranged by the sponsoring company (or their 
designated travel agent) and should be restricted to the 
designated meeting dates (dependent on the travelling time 
involved, this may include arriving 48 hours before the 
meeting and departing soon thereafter). It is inappropriate 
to host Healthcare Professionals at venues that would be 
considered holiday destinations and which are distant from 
their normal place of practice, unless it is a bona fide 
educational meeting, conference or congress, endorsed by a 
Professional Healthcare Association.
Hospitality should be limited to reasonable hotel accom-
modation and meals, coffee breaks and a conference dinner 
or cocktail reception. Spouses, partners, family and/or other 
guests may not benefit from such hospitality.
Companies may not pay for or reimburse Healthcare Pro-
fessional lodging expenses at top category or luxury hotels. 
Companies may also not provide or pay for any stand-alone 
entertainment or any recreational event or activity for any 
Healthcare Professional. 
Whilst working under the umbrella of sustainability and the 
Code, SAMED understands and endorses the importance 
of continued medical education and training and supports 
the idea of holding congresses to further this valuable 
imperative. Consequently, SAMED has convened a sub-
committee, The SAMED Congress Committee, which has 
as its objective to address the difficulties that companies 
face in an effort to ensure continued sponsorship of 
congresses. In this regard, cooperation and collaboration 
between the Societies who host the congresses and Industry 
who sponsors the congresses is of vital importance to 
ensure sustainability.
The committee has drafted a principle document which 
they intend sharing with doctor societies. The document 
includes some suggestions such as having a trade repre-
sentative on the society congress organising committee, 
ensuring that a tender system is used for deciding on event 
organisers (rather than using the same organiser year in and 
year out) and greater transparency regarding the congress 
budget and allocation of sponsorship funds. Ultimately, 
SAMED hopes that with active collaboration, all stakeholders 
will derive a greater return on investment.
for further information please contact  










international meeting. Should such an abstract not be 
accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Prof Johan Brink, President 
of the Cape Western branch of the South African Heart 
Association, Chris Barnard Division of Cardiothoracic 
Surgery, Cape Heart Centre, Faculty of Health Sciences, 
University of Cape Town, Anzio Road, Observatory, 7925 
or alternatively email: johan.brink@uct.ac.za.
Previous recipients of this prestigious award include 
Sandrine Lecour, Roisin Kelle and Liesl Zühlke.  
Applications close on 31 January 2015.
LOUIS vOGELPOEL TRAvELLING SCHOLARSHIP
A gifted and 
enthusiastic 
teacher he was 
instrumental in  
the training of 
generations of 
undergraduates.
A pplications are invited for the annual Louis Vogelpoel Travelling Scholarship for 2014. An amount of up to R15 000 towards the travel and 
accommodation costs of a local or international congress 
will be offered annually by the Cape Western branch of the 
South African Heart Association in memory of one of South 
Africa’s outstanding cardiologists, Dr Louis Vogelpoel. 
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the founding 
members of the Cardiac Clinic at Groote Schuur Hospital 
and University of Cape Town. He had an exceptional 
career of over more than 5 decades as a distinguished 
general physician, cardiologist and horticultural scientist. 
Dr Vogelpoel’s commitment to patient care, teaching and 
personal education is remembered by his many students, 
colleagues and patients. Medical students, house officers, 
registrars and consultants benefited from exposure to his 
unique blend of clinical expertise, extensive knowledge, 
enthusiasm and gracious style. 
A gifted and enthusiastic teacher he was instrumental in 
the training of generations of under-graduates by regular 
bedside tutorials. He served as an outstanding role model 
for post-graduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Cape Western branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the field of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include (1) A brief synopsis of the 
work the applicant wishes to present at the congress and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
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B. BRAUN TRAvEL SCHOLARSHIPS OF THE 
SOUTH AFRICAN HEART ASSOCIATION
You are cordially invited to submit your application for the SA Heart – B. Braun Travel Scholarship to reach the SA 
Heart Office by 30 September 2014.
The scholarship is funded by an educational grant from BBraun to the value of R20 000.00 maximum for international 
meetings and R7 500.00 for local meetings.
This scholarship is available to all members and associate members residing in South Africa. Its primary goal is to assist 
junior colleagues, thereby ensuring their continued participation in local or international scientific meetings or workshops.
REqUIREMENTS
■ Applicants must be fully paid-up members/associate members for at least one year.
■ Applications must include the following:
	 ■	Full details of the meeting/workshop;
	 ■	An abbreviated CV of the applicant; and
	 ■	A breakdown of the expected expenses.
■ Applications must reach the Association a minimum of 3 months ahead of the scheduled event.
RECOMMENDATIONS
■  Acceptance of an abstract at the scientific meeting to be attended. (If acceptance of the abstract is pending, the 
application must still be submitted 3 months prior to the event with a note stating when the approval is to be 
expected. In such a case the scholarship might be granted conditionally – and proof needs to be submitted once 
the abstract has been accepted.);
■ Invitation to participate at the meeting as an invited speaker;
■ Publications in a peer-reviewed journal in the preceding year;
■ Applicants from a previously disadvantaged community; and
■ Applicants younger than 35 years of age.
APPLICATIONS MUST BE ADDRESS TO:




And submitted electronically to erika@saheart.org
Applicants that have benefited from a SA Heart Travel Scholarship  
in the past 3 years need not apply. Preference is further given to members  




THE HEART FAILURE SOCIETY OF SOUTH AFRICA NEWS
A lthough we are in the midst of the cold winter, I am proud to report that the HeFSSA programmes are creating warmth as we move closer to the beginning of the first of the 16 Practitioner meetings that start in July. This programme is now in its 5th year and has been generously sponsored by our corporate supporters: AstraZeneca, Boston Scientific, 
Medtronic, Pharma Dynamics and Servier. The theme for 2014 is Acute Heart Failure. The case based talks for this year’s 
programme were compiled by the HeFSSA exco, Drs Eric Klug, Martin Mpe, Darryl Smith and Jens Hitzeroth. Here follows a 
summary of the planned meetings:
AREA DATE vENUE SPONSORS NAME FACULTY 
George 26 July 2014 Fancourt Pharma Dynamics
Dr JA Lochner 
Dr S Blake
Port Shepstone 02 August 2014 Umdlalo Lodge Pharma Dynamics
Dr K Govender
Dr I Soosiwala
Bloemfontein 02 August 2014 Willow Lake Pharma Dynamics + BSCI
Dr N van der Merwe
Prof H du T Theron
Port Elizabeth 02 August 2014 Ibhayi Hotel Servier
Prof P Commerford 
Dr E Klug
Windhoek 16 August 2014 Arebbusch Pharma Dynamics
Prof K Sliwa 
Dr S Beshir
East London 16 August 2014 East London Golf Club Pharma Dynamics + MDT
Dr D Kettles 
Dr W Lubbe
Durban 16 August 2014 The Hilton Servier + BSCI
Prof AS Mitha
Dr L Ponnusamy
Swakopmund 19 August 2014 Zum Kaiser Hotel Servier
Prof K Sliwa
Dr UR Hahnle
Nelspruit 23 August 2014 Mercure Pharma Dynamics + BSCI
Dr E Maree 
Dr John Benjamin
Cape Town 06 September 2014 Crystal Towers Servier + BSCI
Dr T Lachman
Dr J Hitzeroth
Pretoria 06 September 2014 Casa Toscana Servier + BSCI
Dr A Snyders
Dr C Badenhorst
Potchefstroom 13 September 2014 Willows AstraZeneca
Dr Pro Obel 
Dr Riaz Dawood
East Rand 13 September 2014 Birchwood AstraZeneca + MDT
Dr R Jardine
Dr D Smith
Rustenburg 13 September 2014 Orion Safari Lodge AstraZeneca + MDT Dr M Mpe
Johannesburg 27 September 2014 Sandton Holiday Inn Servier + BSCI
Dr D Smith 
Dr JP Theron
Polokwane 25 October 2014 Fusion Boutique Pharma Dynamics Dr EM Makotoko
    
120 121
Cardio Update for Non-Cardiologists 
HeFSSA further invests in the education of non-cardiologists 
by annually hosting the Cardio Update for Non-Cardiologists. 
This year’s update will take place at the SA Heart Congress 
on 16 October 2014 in Durban at the ICCD. AstraZeneca 
is once again the sponsor and Martin Mpe is the convenor 
of the meeting. He is assisted by Leslie Ponnusamy. The 
topics are:
SA Heart Congress 
HeFSSA will actively participate during the SA Heart 
Congress, 16  - 19 October 2014 at the ICC Durban. 
Dr Eric Klug represents HeFSSA on the organising com-
mittee. All the HeFSSA members are requested to register 
and attend the HeFSSA sessions as advertised. Professors 
McMurray and Clancy will be our special guests and along 
with Professor Anker and local speakers, we will have a 
compelling HeFSSA session. Please also diarise the HeFSSA 
AGM that will take place on Friday, 17 October 2014 at 
17:00.
Continued on page 122
Physicians Update 
Karen Sliwa represented HeFSSA at a Physicians Update 
in Maputo. The workshop took place on 9 April with 
Karen Sliwa also representing SA Heart and PASCAR. Eighty 
five physicians, cardiologists, surgeons and GPs attended 
the lectures given by Professors Albertino Damasceno 
(Mozambique), Ana Mocumbi (Mozambique), Peter Zartner 
(Germany) and Karen Sliwa (South Africa). Topics covered 
were heart failure due to HT and adult congenital heart 
disease with a focus on early detection and management. The 
meeting was a success and the audience was attentive and 
eager to learn. Sanofi Mozambique sponsored the meeting. 
Programmes of interest 
HeFSSA is also investigating a number of possible pro-
grammes of interest: 
 ■  GP Meetings arranged through Hospital Groups. 
 ■  HeFSSA is also liaising with Public Health with the aim of 
improving access to medication for all patients.
 ■  The Kenyan HF Specialist/GP Programme - Medtronic 
and PASCAR have a standing programme with UCT 
training African physicians (with technologist) in treating 
patients with pacing implants.  East Africa, and especially 
Kenya, is very interested in HF. Medtronic suggests a 
HF initiative for training Cardiologist in East Africa. Pos-
sible PASCAR and HeFSSA collaboration were dis-
cussed including Cardiologists from Ethiopia, Kenya and 
Tanzania. The programme might be expanded to include 
separate sessions for GPs. More information regarding 
these initiatives will be discussed in the next newsletter.
HeFSSA is also 
investigating a 
number of possible 
programmes  
of interest.
THURSDAY 16 OCTOBER 
CARDIAC UPDATE
Chairpersons: martin mpe and Leslie ponnusamy
12:00  Registration and lunch
13:00   Chest pain syndromes - when is it angina 
pectoris?
13:30   Pharmacological treatment of Heart Failure with 
reduced EF
14:00  CAD in a patient with diabetes
14:30  Management of lipid disorders
15:00  TEA BrEAK
15:30  Ethics
16:00  Atrial Fibrillation and Stroke
16:30  Interactive ECG session




HeFSSA is a Special Interest Group within the SA Heart 
Association whose initiatives are driven by the Executive 
Committee.
The Executive Committee is: 
Eric Klug  President
martin mpe  Vice-President
Darryl Smith  Treasurer
Jens Hitzeroth  Secretary





We need to thank them for their hard work that includes 
generously donating both their time and knowledge.
Until recently Dr Pro Obel has been an active executive 
member of the society. He has resigned as Exco member, 
but is still contributing to the society. He is one of the 
HeFSSA GP Programme faculty members and has been 
presenting to the GPs in Potchefstroom since 2012. We 
wish him the best for all his future endeavours and will 
approach him in the future to gain some of his valuable 
input.
The HeFSSA Executive would also like to thank our 
loyal industry supporters: AstraZeneca, Boston Scientific, 
Medtronic, Merck, Novartis and Servier.
please contact the HefSSA office if you would 
like to contribute to any of these programmes or 
if you need more information.
Contact details
george Nel
info@hefssa.org or 083 458 5954
Eric Klug
President HeFSSA
The case for a second cardiologist in CathLab
Bloemfontein tak, SA Heart 
Die bestuur van die Bloemfontein tak van SA Heart wil sy diepe kommer uitspreek oor die krisis waarin kardiologie dienste 
in die Vrystaat en Noord-Kaap tans is. Na die aftrede van Prof Marx en die afdanking van Prof Theron is daar tans geen 
gekwalifiseerde kardioloe wat in diens van die staat is nie en dit beteken dat geen gespesialiseerde kardiologiese dienste tans 
aan staatspasiente in die Vrystaat en Noord-Kaap gelewer kan word nie.
’n Groep van 4 privaat kardioloe het op versoek van die mediese fakulteit vir die afgelope 3 maande daar ’n vrywillige diens 
gelewer, maar pogings van hierdie groep om ’n meer permanente onderneming met die staat die beding, is deur die CEO van 
Universitas hospitaal geignoreer. Die groep het toe eenparig besluit dat hulle onder huidige omstandighede nie langer betrokke 
kan wees nie.
Hierdie besluit is nie ligtelik geneem nie, aangesien dit verreikende gevolge inhou, nie net vir dienslewering nie, maar ook 
opleiding van voor- en nagraadse mediese studente, wat weer die akkredititasie van sekere departemente van die mediese 
fakulteit in gedrang kan bring.
Pasiente se lewens word tans in gevaar gestel weens die onvermoe of onwilligheid van persone in bestuursposisies om hierdie 
probleem daadwerklik aan te spreek en daarom wil hierdie vereniging ’n ernstige beroep doen op die Vrystaatse en Nasionale 
departemente van Gesondheid om in te gryp om hierdie situasie te beredder.
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